Daniel J. O'Connor's Net Worth
$766 Thousand
Who is Daniel J. O'Connor?
Daniel J. O'Connor does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include ZyVersa Therapeutics, Inc., Ambrx Biopharma, Inc., Advaxis, Inc., SEELOS THERAPEUTICS, INC., ONCOSEC MEDICAL Inc, Ambrx Biopharma Inc., and IMCLONE SYSTEMS INC.
SEC CIK
Daniel J. O'Connor's CIK is 0001376847
Past Insider Trading and Trends
2013 was Daniel J. O'Connor's most active year for acquiring shares with 20 total transactions. Daniel J. O'Connor's most active month to acquire stocks was the month of December. 2016 was Daniel J. O'Connor's most active year for disposing of shares, totalling 15 transactions. Daniel J. O'Connor's most active month to dispose stocks was the month of December. 2018 saw Daniel J. O'Connor paying a total of $401,600.50 for 3,526,667 shares, this is the most they've acquired in one year. In 2023 Daniel J. O'Connor cashed out on 50,012 shares for a total of $491,117.84, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
ZyVersa Therapeutics, Inc. (ZVSA) Snapshot price: $2.95
Chief Executive Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 1.38M |
—
|
—
| 1.38M |
Dec 12
| |||
Form 4
|
∞
| 42.01K |
—
|
—
| 42.01K |
Jan 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Ambrx Biopharma, Inc. (AMAM) No price found
President and CEODaniel J. O'Connor used to own units in Common Stock but no longer holds any shares there. In the year 2023 Daniel J. O'Connor acquired a total of 750,000 shares in Ambrx Biopharma, Inc., Daniel also disposed a total of 98,214 shares of Ambrx Biopharma, Inc. equalling to $491,117.84.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -48.20K |
—
|
—
|
0
|
Mar 7
| |||
Form 4
| +122.28% | 750K |
—
|
—
| 1.36M |
Dec 11
| |||
Form 4
| -12.73% | -50.01K |
$9.82 | -$491,117.84 | 342.85K |
Oct 27
| |||
| No matching records found | |||||||||
Advaxis, Inc. (ADXS) Snapshot price: $0.14
Chief Executive OfficerDaniel J. O'Connor owns 618,352 units of Common Stock which is worth $86,569.28. In the year 2013 Daniel J. O'Connor filed a total of 57 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +0.12% | 742 |
$6.49 | $4,815.58 | 618.35K |
Jun 30
| |||
Form 4
| +40.20% | 177.1K |
—
|
—
| 617.61K |
Jun 19
| |||
Form 4
| +0.10% | 421 |
$8.07 | $3,397.47 | 440.51K |
May 31
| |||
Form 4
| +48.31% | 143.34K |
$8.56 | $2,987.44 | 440.09K |
Apr 28 - May 1
| |||
Form 4
| +0.12% | 365 |
$8.17 | $2,982.05 | 296.74K |
Mar 31
| |||
Form 4
| +0.13% | 386 |
$8.79 | $3,392.94 | 296.38K |
Feb 28
| |||
Form 4
| +0.12% | 369 |
$8.96 | $3,306.24 | 295.99K |
Jan 31
| |||
Form 4
| +0.20% | 600 |
$7.16 | $4,296.00 | 295.62K |
Dec 30
| |||
Form 4
| +0.12% | 366 |
$8.31 | $3,041.46 | 295.02K |
Nov 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 3
| |||
Form 4
| -2.64% | -8.00K |
$8.20 | -$66,647.56 | 294.66K |
Oct 31 - Nov 2
| |||
Form 4
| +0.10% | 304 |
$10.69 | $3,249.76 | 302.66K |
Sep 30
| |||
Form 4
| +0.09% | 282 |
$11.53 | $3,251.46 | 302.36K |
Aug 31
| |||
Form 4
| +0.18% | 571 |
$8.34 | $4,762.14 | 310.34K |
Jul 29
| |||
Form 4
| +0.39% | 1.2K |
$8.09 | $9,716.09 | 309.77K |
Jun 30
| |||
Form 4
| +0.24% | 752 |
$9.26 | $6,963.52 | 308.57K |
May 31
| |||
Form 4
| -2.42% | -7.62K |
$7.64 | -$57,107.51 | 307.82K |
Apr 29 - May 2
| |||
Form 4
| +0.25% | 771 |
$9.03 | $6,962.13 | 315.44K |
Mar 31
| |||
Form 4
| +0.41% | 1.27K |
$5.46 | $6,961.50 | 314.67K |
Feb 29
| |||
Form 4
| -2.55% | -8.21K |
$6.85 | -$56,494.00 | 313.39K |
Jan 29
| |||
Form 4
| +0.23% | 765 |
$10.06 | $7,695.90 | 332.95K |
Dec 31
| |||
Form 4
| +0.14% | 457 |
$12.07 | $5,515.99 | 332.19K |
Nov 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 5
| |||
Form 4
| -2.36% | -8.03K |
$11.66 | -$98,822.20 | 331.73K |
Oct 30
| |||
Form 4
| +0.16% | 536 |
$10.23 | $5,483.28 | 339.76K |
Sep 30
| |||
Form 4
| +0.11% | 371 |
$14.80 | $5,490.80 | 339.23K |
Aug 31
| |||
Form 4
| -2.34% | -8.13K |
$16.08 | -$125,204.66 | 338.86K |
Jul 31
| |||
Form 4
| +0.10% | 341 |
$20.33 | $6,932.53 | 346.99K |
Jun 30
| |||
Form 4
| +0.08% | 282 |
$25.16 | $7,095.12 | 358.05K |
May 29
| |||
Form 4
| +0.12% | 413 |
$16.81 | $6,942.53 | 357.77K |
Apr 30
| |||
Form 4
| +0.13% | 461 |
$14.44 | $6,656.84 | 357.35K |
Mar 30 - Mar 31
| |||
Form 4
| +0.21% | 740 |
$9.00 | $6,660.00 | 356.89K |
Feb 27
| |||
Form 4
| +17.19% | 52.23K |
$9.85 | $9,790.90 | 356.15K |
Dec 10 - Jan 30
| |||
Form 4
| +0.26% | 780 |
$8.01 | $6,247.80 | 303.92K |
Dec 31
| |||
Form 4
| +0.67% | 2K |
$3.12 | $6,249.36 | 303.14K |
Nov 28
| |||
Form 4
| +0.66% | 1.97K |
$3.18 | $6,255.06 | 301.14K |
Oct 31
| |||
Form 4
| +0.49% | 1.46K |
$3.36 | $4,915.68 | 299.17K |
Sep 30
| |||
Form 4
| +0.43% | 1.27K |
$3.88 | $4,915.96 | 297.71K |
Aug 29
| |||
Form 4
| -1.79% | -5.40K |
$3.38 | -$24,643.26 | 296.44K |
Aug 1
| |||
Form 4
| -5.17% | -16.47K |
$4.03 | -$66,366.04 | 301.84K |
Jul 17
| |||
Form 4
| +0.88% | 2.77K |
$3.15 | -$3,773.70 | 318.31K |
Jul 1
| |||
Form 4
| +1.45% | 4.52K |
$2.72 | -$6,457.28 | 315.54K |
May 1
| |||
Form 4
| +1.08% | 3.33K |
$3.00 | $9,999.00 | 311.02K |
Mar 31
| |||
Form 4
| +0.49% | 1.54K |
$4.49 | -$2,478.48 | 314.35K |
Jan 31
| |||
Form 4
| +286.31% | 231.84K |
$4.03 | -$73,184.80 | 312.81K |
Jan 7
| |||
Form 4
| +9.10% | 6.75K |
$4.03 | -$16,414.19 | 80.97K |
Jan 7
| |||
Form 4
| +11.22% | 7.49K |
$3.70 | $27,694.50 | 74.22K |
Dec 31
| |||
Form 4/A
| +1.35% | 1.26K |
$4.37 | $5,596.95 | 94.94K |
Aug 31 - Sep 30
| |||
Form 4
| +6.61% | 4.14K |
$4.43 | $18,331.34 | 66.74K |
Oct 31
| |||
Form 4/A
| +65.33% | 24.24K |
$4.03 | $97,736.42 | 61.34K |
Jul 31 - Oct 24
| |||
Form 4/A
| +660.25% | 32.22K |
$4.79 | $154,194.70 | 37.1K |
Jan 31 - Jun 30
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| +28.27% | 13.5K |
$4.00 | $54,000.00 | 61.26K |
Oct 24
| |||
Form 4
| +243.36% | 2.64M |
$0.03 | $66,700.95 | 3.72M |
Mar 14 - May 20
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
SEELOS THERAPEUTICS, INC. (SEEL) Snapshot price: $0.2305
InvestorDaniel J. O'Connor owns 16,000 units of Common Stock which is worth $3,688.00. From 2019 to 2024 Daniel J. O'Connor acquired a total of 16,000 shares in SEELOS THERAPEUTICS, INC. at a cost of $9,788.80.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 5
| |||
Form 4
|
∞
| 16K |
$0.61 | $9,788.80 | 16K |
Jun 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ONCOSEC MEDICAL Inc (ONCSQ) Snapshot price: $0.111
CEO and PresidentDaniel J. O'Connor owns 96,097 units of Common Stock which is worth $10,666.77. In the year 2017 Daniel J. O'Connor filed a total of 19 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -3.20% | -3.17K |
$4.86 | -$15,415.92 | 96.1K |
Apr 30
| |||
Form 4
| -3.32% | -3.41K |
$7.71 | -$26,314.23 | 99.27K |
Feb 1
| |||
Form 4
| -3.10% | -3.28K |
$3.79 | -$12,431.20 | 102.68K |
Nov 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 24
| |||
Form 4
| -2.87% | -3.13K |
$4.20 | -$13,158.60 | 105.96K |
Jul 31
| |||
Form 4
| +73.21% | 46.11K |
$2.23 | -$99,170.33 | 109.09K |
May 29
| |||
Form 4
| -4.65% | -3.08K |
$1.79 | -$5,504.25 | 62.99K |
Apr 30
| |||
Form 4
| -3.86% | -2.65K |
$1.96 | -$5,201.84 | 66.06K |
Jan 31
| |||
Form 4
| -3.00% | -2.13K |
$2.16 | -$4,596.48 | 68.72K |
Oct 31
| |||
Form 4
| -2.95% | -2.16K |
$2.23 | -$4,807.88 | 70.84K |
Jul 31
| |||
Form 4
| -2.84% | -21.36K |
$0.57 | -$12,066.70 | 729.99K |
Apr 30
| |||
Form 4
| -3.26% | -25.32K |
$0.88 | -$22,279.84 | 751.35K |
Jan 31
| |||
Form 4
| +2,812.46% | 750K |
—
|
—
| 776.67K |
Dec 24
| |||
Form 4
| +60.00% | 10K |
$0.91 | $9,100.00 | 26.67K |
Nov 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 3
| |||
Form 4
|
∞
| 16.67K |
$1.50 | $25,000.50 | 16.67K |
Feb 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||